IMR Press / FBL / Volume 12 / Issue 13 / DOI: 10.2741/2553

Frontiers in Bioscience-Landmark (FBL) is published by IMR Press from Volume 26 Issue 5 (2021). Previous articles were published by another publisher on a subscription basis, and they are hosted by IMR Press on imrpress.com as a courtesy and upon agreement with Frontiers in Bioscience.

Article
Molecular ultrasound imaging using microbubble contrast agents
Show Less
1 Department of Biomedical Engineering, 1 Shields Avenue, University of California, Davis, California, 95616, USA
2 Cardiovascular Research Center, University of Virginia, 415 Lane Road,, Charlottesville, VA, 22903, USA
Front. Biosci. (Landmark Ed) 2007, 12(13), 5124–5142; https://doi.org/10.2741/2553
Published: 1 September 2007
Abstract

Molecular imaging is a new field in bioscience which, by virtue of utilizing a contrast agent or reporter, facilitates early detection of the disease processes before phenotypic changes become apparent. Molecular imaging with ultrasound utilizes contrast agents that bear adhesion ligands designed to bind tissue markers specific for a disease process. Such agents can be detected by ultrasound with a great degree of sensitivity, providing both anatomical reference information as well as additional data such as molecular characteristics of the interrogated region. This review summarizes current applications and challenges of molecular ultrasound imaging and offers future technologies which likely follow as an improvement to the existing techniques. Due to the widespread availability of ultrasound and ease of use, molecular ultrasound imaging is likely to emerge as a powerful diagnostic technique.

Keywords
Ultrasound
Microbubble
Targeted Imaging
Molecular Imaging
Review
Share
Back to top